Lennox Gastaut Syndrome
Showing 1 - 19 of 19
Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies Trial run by the Longboard
Available
- Dravet Syndrome
- +2 more
-
Bethesda, MarylandMid-Atlantic Epilepsy and Sleep Center
Nov 19, 2023
Lennox Gastaut Syndrome Trial in Worldwide (ZX008 0.2 or 0.8 mg/kg/day, Matching Placebo)
Active, not recruiting
- Lennox Gastaut Syndrome
- ZX008 0.2 or 0.8 mg/kg/day
- Matching Placebo
-
Tucson, Arizona
- +76 more
Jan 27, 2023
Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox Gastaut Syndrome Trial in United States (LP352, Placebo)
Recruiting
- Developmental and Epileptic Encephalopathy
- +2 more
- LP352
- Placebo
-
Little Rock, Arkansas
- +25 more
Jan 9, 2023
Dravet Syndrome, Lennox Gastaut Syndrome, Epileptic Encephalopathy Trial in Worldwide (ZX008 (Fenfluramine Hydrochloride))
Active, not recruiting
- Dravet Syndrome
- +2 more
- ZX008 (Fenfluramine Hydrochloride)
-
Tucson, Arizona
- +86 more
Jan 5, 2023
Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable Trial in United States (RNS System)
Recruiting
- Epilepsy
- +4 more
- RNS System
-
Birmingham, Alabama
- +5 more
Dec 28, 2022
Dravet Syndrome, Lennox Gastaut Syndrome Trial in Atlanta, Tacoma (ZX008 0.2 to 0.8 mg/kg/day, Cannabidiol)
Completed
- Dravet Syndrome
- Lennox Gastaut Syndrome
- ZX008 0.2 to 0.8 mg/kg/day
- Cannabidiol
-
Atlanta, Georgia
- +1 more
Oct 31, 2022
Epidyolex® in Lennox Gastaut and Dravet Syndrome:Observational
Not yet recruiting
- Lennox Gastaut Syndrome
- Dravet Syndrome
- Epidiolex 100 mg/mL Oral Solution
-
Roma, ItalyOspedale Pediatrico Bambino Gesù (OPBG)
Aug 1, 2022
Primary Generalized Tonic-Clonic or Partial Onset Seizures, Lennox Gastaut Syndrome Trial in Worldwide (Perampanel)
Available
- Primary Generalized Tonic-Clonic or Partial Onset Seizures
- Lennox Gastaut Syndrome
-
Brussels, Belgium
- +21 more
May 25, 2022
Palliative Surgery Versus Additional Anti-Seizure Medications
Not yet recruiting
- Lennox Gastaut Syndrome
- (no location specified)
May 10, 2022
Lennox Gastaut Syndrome Trial (Clemizole HCl, Placebo to match EPX-100)
Not yet recruiting
- Lennox Gastaut Syndrome
- Clemizole HCl
- Placebo to match EPX-100
- (no location specified)
Apr 5, 2022
Cannabidiol (CBD) and Its Effects in Severe Epilepsy
Withdrawn
- Dravet Syndrome
- Lennox Gastaut Syndrome
- (no location specified)
Dec 2, 2021
Epilepsy, Lennox Gastaut Syndrome Trial in Leuven (Fenfluramine)
Active, not recruiting
- Epilepsy
- Lennox Gastaut Syndrome
-
Leuven, BelgiumUniversity Hospitals UZ Leuven
Jan 26, 2021
Dravet Syndrome, Lennox Gastaut Syndrome Trial in Seoul (Cannabidiol)
Unknown status
- Dravet Syndrome
- Lennox Gastaut Syndrome
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University College of Medicine
Oct 26, 2020
Epilepsy, Lennox Gastaut Syndrome Trial in Worldwide (GWP42003-P, Placebo control)
Completed
- Epilepsy
- Lennox Gastaut Syndrome
- GWP42003-P
- Placebo control
-
Birmingham, Alabama
- +28 more
Jul 26, 2018